Skip to main content
. 2021 Jun 15;14:1773–1783. doi: 10.2147/JPR.S304805

Figure 2.

Figure 2

Quarterly (Q3 2016-Q4 2019) rates of past 30-day NMU (A) per 100 ASI-MV assessments, (B) per 100,000 prescriptions dispensed, and (C) per 1,000,000 units dispensed for Xtampza ER and comparator oxycodone products.

Note: Xtampza ER was added to the ASI-MV in Q3 2017.

Abbreviations: ER, extended-release; IR, immediate-release; ASI-MV, Addiction Severity Index-Multimedia Version; NMU, nonmedical use.